Sanofi Consumer Healthcare India share price
You have to be logged in to add this to Watchlist.- ₹4,570.00(-0.57%)December 15, 2025 15:28:48 PM IST
- NSE
- BSE
- Vol : 0.95 K (NSE + BSE)Last 20 day avg : 3.41 K
Sanofi Consumer Healthcare India is trading -0.57% lower at Rs 4,570.00 as compared to its last closing price. Sanofi Consumer Healthcare India has been trading in the price range of 4,624.45 & 4,557.20. Sanofi Consumer Healthcare India has given -6.30% in this year & -0.82% in the last 5 days. Sanofi Consumer Healthcare India has TTM P/E ratio 49.89 as compared to the sector P/E of 28.49.There are 1 analysts who have initiated coverage on Sanofi Consumer Healthcare India. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 62.90 Crores in its last quarter.Listed peers of Sanofi Consumer Healthcare India include Sun Pharmaceutical Industries (-0.01%), Cipla (-0.66%), Torrent Pharmaceuticals (0.07%).The Mutual Fund holding in Sanofi Consumer Healthcare India was at 13.34% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Sanofi Consumer Healthcare India was at 2.93% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 15, 2025, 03:28 PM UTC
- Debt To EquityHigher than industry0.07The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.19Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,794.20 | -0.01 | 4,30,430.20 | 37.94 | 6.04 | 0.88 | 0.50 |
| Cipla | Bearish | 1,507.25 | -0.66 | 1,21,916.05 | 23.33 | 3.94 | 0.85 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 3,791.95 | 0.07 | 1,28,645.70 | 66.64 | 16.92 | 0.84 | 17.62 |
| Dr Reddy's Laboratories | Bullish | 1,277.40 | -0.18 | 1,06,622.02 | 18.80 | 3.17 | 0.63 | 2.34 |
| Divi's Laboratories | Neutral | 6,342.85 | -1.31 | 1,68,708.24 | 78.27 | 11.47 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-12 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-02 | Quarterly Results |
| 2025-02-20 | Audited Results & Final Dividend |
| 2024-11-12 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE0UOS01011
- BSE Code544250
- NSE CodeSANOFICONR
- Management Info
Sanofi Consumer Healthcare India is trading at 4570.00 as on Mon Dec 15 2025 09:58:48. This is -0.57% lower as compared to its previous closing price of 4596.20.
The market capitalization of Sanofi Consumer Healthcare India is 10524.99 Cr as on Mon Dec 15 2025 09:58:48.
The average broker rating on Sanofi Consumer Healthcare India is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Sanofi Consumer Healthcare India is 5954.00 whereas the 52 wk low is 4360.30
Sanofi Consumer Healthcare India can be analyzed on the following key metrics -
- TTM P/E: 49.89
- Sector P/E: 28.49
- Dividend Yield: 1.19%
- D/E ratio: -
Sanofi Consumer Healthcare India reported a net profit of 181.00 Cr in 2024.
The Mutual Fund Shareholding was 13.34% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Sanofi Consumer Healthcare India QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.